US0441861046 - Common Stock - After market: 105.31 0 (0%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-02-02 | BMO Capital | Maintains | Outperform |
2023-02-02 | Wells Fargo | Maintains | Equal-Weight |
2023-02-02 | JP Morgan | Downgrade | Neutral -> Underweight |
2023-01-26 | Mizuho | Maintains | Buy |
2023-01-26 | BMO Capital | Maintains | Outperform |
2023-01-12 | Mizuho | Maintains | Buy |
2023-01-11 | UBS | Maintains | Buy |
2022-11-09 | Wells Fargo | Maintains | Equal-Weight |
2022-11-08 | Credit Suisse | Maintains | Outperform |
2022-10-18 | Wells Fargo | Maintains | Equal-Weight |
2022-09-12 | Credit Suisse | Initiate | Outperform |
2022-07-28 | BMO Capital | Maintains | Outperform |
2022-07-28 | Wells Fargo | Maintains | Equal-Weight |
2022-07-27 | UBS | Maintains | Buy |
2022-07-19 | Mizuho | Maintains | Buy |
2022-07-18 | Wells Fargo | Maintains | Equal-Weight |
2022-07-06 | Mizuho | Maintains | Buy |
2022-04-29 | BMO Capital | Maintains | Outperform |
2022-04-19 | Mizuho | Maintains | Buy |
2022-04-18 | Wells Fargo | Maintains | Equal-Weight |
2022-04-13 | Deutsche Bank | Maintains | Buy |
2022-02-03 | Mizuho | Maintains | Buy |
2022-01-24 | BMO Capital | Maintains | Outperform |
2022-01-20 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
2022-01-19 | JP Morgan | Maintains | Neutral |
2021-11-15 | Wells Fargo | Maintains | Overweight |
2021-11-12 | Mizuho | Maintains | Buy |
2021-11-11 | Monness, Crespi, Hardt | Downgrade | Buy -> Neutral |
2021-11-11 | Wells Fargo | Maintains | Overweight |
2021-10-13 | Mizuho | Initiate | Buy |
Find the competitors with the best analyst ratings on the USA